Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
Samrawit Terefe, Pediatrician at Motite Fura Hospital, shared a post on LinkedIn:
“A notification from a Telegram group for O-negative blood donors in Hawassa popped up on my phone.
A woman with severe anemia urgently needed more than two units of blood to undergo a surgery.
Her blood type: O-negative.
At that time, the blood bank – serving a catchment population of more than 10 million – had only one unit available.
Despite ongoing campaigns and tirelesseffortof the blood banks, blood shortages remain a constant challenge.
And moments like this highlight a deeper issue: our culture of voluntary blood donation is still far from where it needs to be.
The O-negative Telegram group was created out of necessity.
O-negative blood can be given to anyone, yet it can only be received from O-negative donors – making it incredibly scarce.
What’s striking, and at times disheartening, is that even individuals who have previously benefited from blood donations – either personally or through loved ones – are sometimes reluctant to give back or even join such initiatives.
And yet, there is hope.
Thanks to the swift and selfless response of donors in these groups – both in Addis Ababa and Hawassa – many lives have been saved.
This patient, too, underwent surgery after my self and another group member donated and she is now stable.
This experience leaves me with an important question:
How can we strengthen a culture of regular, voluntary blood donation in our communities?
One practical step could be scaling similar donor networks across cities.
These small, coordinated efforts are already making a life-saving difference.
Because in the end, blood is not manufactured – it is given.
Let us give blood
Let us save lives!!!”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?